SETDB1 anticorps (AA 201-300) (Biotin)

N° du produit ABIN1392643

Détail du produit anti-SETDB1 anticorps (Biotin)

Antigène: SETDB1 (SET Domain, Bifurcated 1 (SETDB1))

Épitope: AA 201-300

Reactivité: Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SETDB1 est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Réactivité croisée: Rat

Homologie: Human,Mouse,Dog,Cow,Sheep,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human SETDB1

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500
IP(1-2 μg)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur SETDB1

Antigène: SETDB1 (SET Domain, Bifurcated 1 (SETDB1))

Autre désignation: KMT1E/SETDB1 (SETDB1 Produits)

Synonymes: anticorps ESET, anticorps H3-K9-HMTase4, anticorps KG1T, anticorps KMT1E, anticorps TDRD21, anticorps AU022152, anticorps mKIAA0067, anticorps SETDB1, anticorps NV10069, anticorps fc07d03, anticorps si:ch211-81a5.6, anticorps wu:fc07d03, anticorps im:7143091, anticorps wu:fa04a12, anticorps wu:fj80h02, anticorps zgc:152899, anticorps SET domain bifurcated 1, anticorps SET domain, bifurcated 1, anticorps myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11, anticorps histone-lysine N-methyltransferase SETDB1, anticorps SET domain, bifurcated 1a, anticorps SET domain bifurcated 1 L homeolog, anticorps SET domain, bifurcated 1b, anticorps SETDB1, anticorps Setdb1, anticorps MLLT11, anticorps LOC100120014, anticorps LOC100461671, anticorps setdb1a, anticorps setdb1.L, anticorps setdb1b

Sujet:

Synonyms: ESET, KG1T, KMT1E, TDRD21, H3-K9-HMTase4, Histone-lysine N-methyltransferase SETDB1, ERG-associated protein with SET domain, Histone H3-K9 methyltransferase 4, H3-K9-HMTase 4, Lysine N-methyltransferase 1E, SET domain bifurcated 1, SETDB1, KIAA0067

Background: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. H3 'Lys-9' trimethylation is coordinated with DNA methylation. Probably forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1. SETDB1 is targeted to histone H3 by TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (PubMed:27029610).

ID gène: 9869

UniProt: Q15047